TIAA CREF Investment Management’s LeMaitre Vascular LMAT Stock Holding History

TIAA CREF Investment Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.79M	Buy	57,840 +2,002	+4%	+$53.4K	﹤0.01%	2051
2018 Q4	$1.32M	Sell	55,838 -10,100	-15%	-$276K	﹤0.01%	2174
2018 Q3	$2.55M	Sell	65,938 -3,529	-5%	-$127K	﹤0.01%	1992
2018 Q2	$2.33M	Sell	69,467 -57,149	-45%	-$2.03M	﹤0.01%	2090
2018 Q1	$4.59M	Sell	126,616 -1,188	-0.9%	-$41.2K	﹤0.01%	1603
2017 Q4	$4.07M	Buy	127,804 +2,250	+2%	+$77.1K	﹤0.01%	1734
2017 Q3	$4.7M	Buy	125,554 +9,205	+8%	+$313K	﹤0.01%	1669
2017 Q2	$3.63M	Buy	116,349 +11,192	+11%	+$323K	﹤0.01%	1801
2017 Q1	$2.59M	Buy	105,157 +6,472	+7%	+$152K	﹤0.01%	1977
2016 Q4	$2.5M	Buy	98,685 +18,617	+23%	+$413K	﹤0.01%	2053
2016 Q3	$1.59K	Buy	80,068 +508	+0.6%	+$8.88K	﹤0.01%	2300
2016 Q2	$1.14M	Buy	79,560 +1,328	+2%	+$20.3K	﹤0.01%	2443
2016 Q1	$1.21M	Buy	78,232 +5,452	+7%	+$78.2K	﹤0.01%	2369
2015 Q4	$1.25M	Buy	72,780 +14,687	+25%	+$213K	﹤0.01%	2450
2015 Q3	$708K	Buy	58,093 +1,900	+3%	+$24.4K	﹤0.01%	2763
2015 Q2	$678K	Buy	+56,193	New	+$553K	﹤0.01%	2868

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TIAA CREF Investment Management's LMAT Position: Q1 2019 in Review

TIAA CREF Investment Management increased its LeMaitre Vascular (LMAT) stake by 3.6% in Q1 2019, buying an estimated $53.4K and bringing the position to 57,840 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2051.

TIAA CREF Investment Management first reported a position in LMAT in Q2 2015 and has held it in 16 quarters since. The position peaked at $4.7M in Q3 2017. 155 funds tracked by Wall St. Rank hold LMAT as of Q1 2019.

TIAA CREF Investment Management held 57,840 shares of LeMaitre Vascular worth $1.79M as of Q1 2019.
TIAA CREF Investment Management bought 2,002 LeMaitre Vascular shares in Q1 2019, an estimated $53.4K.
LeMaitre Vascular made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2051 holding.
TIAA CREF Investment Management first reported a position in LeMaitre Vascular in Q2 2015 and has held it in 16 quarters since.
TIAA CREF Investment Management's LeMaitre Vascular position peaked at $4.7M in Q3 2017.
155 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.